FdaApplication

BLA 761480

Back to search

Identifiers

Properties

PropertyValue
applicant_nameLupin Limited (Biotech Division)
application_typeBLA
approval_date2026-06-02

Products (4)

ProductActive ingredientStrengthDosage form
RANLUSPECRANIBIZUMAB-HKDZ6MG/ML (0.3MG/0.05ML)Injection
RANLUSPECRANIBIZUMAB-HKDZ10MG/ML (0.5MG/0.05ML)Injection
RANLUSPEC—6MG/ML (0.3MG/0.05ML)Injection
RANLUSPEC—10MG/ML (0.5MG/0.05ML)Injection

4 products